1 Biotech Stock to Buy Hand Over Fist and 1 to Avoid [Yahoo! Finance]
CRISPR Therapeutics AG - Common Shares (CRSP)
Last crispr therapeutics ag - common shares earnings: 8/7 05:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
nasdaq.com/symbol/crsp/real-time
Company Research
Source: Yahoo! Finance
Of course, it's not hard to find stocks that have performed both better and worse than the sector average. Consider CRISPR Therapeutics (NASDAQ: CRSP) , a mid-cap biotech that is down by 13% this year. On the other end of the spectrum is Ocugen (NASDAQ: OCGN) , a small-cap drugmaker whose shares are up a stunning 164%. That said, it's not a good idea to rely on six months' worth of data to decide which stocks to buy. These two biotechs will likely reverse positions over the long run, with CRISPR performing much better than Ocugen. Read on to find out why the former is worth investing in while the latter should be avoided. XBI Total Return Level data by YCharts. The stock to buy: CRISPR Therapeutics Innovation is one of the keys to success in the biotech industry . CRISPR Therapeutics seems to have what it takes. It is an expert in the exciting field of gene editing. Unlike many of its pure play gene-editing competitors, CRISPR already has an approved product on the market.
Show less
Read more
Impact Snapshot
Event Time:
CRSP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRSP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRSP alerts
High impacting CRISPR Therapeutics AG - Common Shares news events
Weekly update
A roundup of the hottest topics
CRSP
News
- Is CRISPR Therapeutics AG (CRSP) the Most Promising Biotech Stock According to Hedge Funds? [Yahoo! Finance]Yahoo! Finance
- CRISPR Therapeutics AG (CRSP) Advances While Market Declines: Some Information for Investors [Yahoo! Finance]Yahoo! Finance
- CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: Here's Why [Yahoo! Finance]Yahoo! Finance
- This Healthcare Growth Stock Could Be a Steal of a Deal Right Now [Yahoo! Finance]Yahoo! Finance
- CRISPR Therapeutics AG (NASDAQ: CRSP) had its price target lowered by analysts at Royal Bank of Canada from $60.00 to $53.00. They now have a "sector perform" rating on the stock.MarketBeat
CRSP
Earnings
- 8/5/24 - Miss
CRSP
Sec Filings
- 10/15/24 - Form 4
- 10/15/24 - Form 4
- 8/12/24 - Form 4
- CRSP's page on the SEC website